Agricultural Inputs
Compare Stocks
2 / 10Stock Comparison
CTVA vs LIN
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
CTVA vs LIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Agricultural Inputs | Chemicals - Specialty |
| Market Cap | $54.89B | $232.56B |
| Revenue (TTM) | $17.89B | $34.66B |
| Net Income (TTM) | $1.16B | $7.13B |
| Gross Margin | 33.5% | 46.0% |
| Operating Margin | 13.8% | 28.8% |
| Forward P/E | 22.3x | 28.1x |
| Total Debt | $2.58B | $26.99B |
| Cash & Equiv. | $4.52B | $5.06B |
CTVA vs LIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Corteva, Inc. (CTVA) | 100 | 299.4 | +199.4% |
| Linde plc (LIN) | 100 | 248.0 | +148.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CTVA vs LIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CTVA is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.29, Low D/E 10.6%, current ratio 1.43x
- Lower P/E (22.3x vs 28.1x)
- +32.1% vs LIN's +13.6%
LIN carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 6 yrs, beta 0.24, yield 1.2%
- Rev growth 3.0%, EPS growth 7.1%, 3Y rev CAGR 0.6%
- 376.9% 10Y total return vs CTVA's 195.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.0% revenue growth vs CTVA's 2.9% | |
| Value | Lower P/E (22.3x vs 28.1x) | |
| Quality / Margins | 20.6% margin vs CTVA's 6.5% | |
| Stability / Safety | Beta 0.24 vs CTVA's 0.29 | |
| Dividends | 1.2% yield, 6-year raise streak, vs CTVA's 0.9% | |
| Momentum (1Y) | +32.1% vs LIN's +13.6% | |
| Efficiency (ROA) | 8.3% ROA vs CTVA's 2.7%, ROIC 11.3% vs 8.5% |
CTVA vs LIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CTVA vs LIN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
LIN leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 1.9x CTVA's $17.9B. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to CTVA's 6.5%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $17.9B | $34.7B |
| EBITDAEarnings before interest/tax | $3.4B | $12.1B |
| Net IncomeAfter-tax profit | $1.2B | $7.1B |
| Free Cash FlowCash after capex | $2.1B | $5.1B |
| Gross MarginGross profit ÷ Revenue | +33.5% | +46.0% |
| Operating MarginEBIT ÷ Revenue | +13.8% | +28.8% |
| Net MarginNet income ÷ Revenue | +6.5% | +20.6% |
| FCF MarginFCF ÷ Revenue | +11.5% | +14.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.0% | +8.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +12.6% | +13.4% |
Valuation Metrics
CTVA leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 34.4x trailing earnings, LIN trades at a 33% valuation discount to CTVA's 51.1x P/E. Adjusting for growth (PEG ratio), LIN offers better value at 1.36x vs CTVA's 4.28x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $54.9B | $232.6B |
| Enterprise ValueMkt cap + debt − cash | $52.9B | $254.5B |
| Trailing P/EPrice ÷ TTM EPS | 51.10x | 34.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.30x | 28.12x |
| PEG RatioP/E ÷ EPS growth rate | 4.28x | 1.36x |
| EV / EBITDAEnterprise value multiple | 13.85x | 20.04x |
| Price / SalesMarket cap ÷ Revenue | 3.15x | 6.84x |
| Price / BookPrice ÷ Book value/share | 2.26x | 5.92x |
| Price / FCFMarket cap ÷ FCF | 19.50x | 45.70x |
Profitability & Efficiency
LIN leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $5 for CTVA. CTVA carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to LIN's 0.68x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +4.6% | +17.8% |
| ROA (TTM)Return on assets | +2.7% | +8.3% |
| ROICReturn on invested capital | +8.5% | +11.3% |
| ROCEReturn on capital employed | +8.6% | +13.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.11x | 0.68x |
| Net DebtTotal debt minus cash | -$1.9B | $21.9B |
| Cash & Equiv.Liquid assets | $4.5B | $5.1B |
| Total DebtShort + long-term debt | $2.6B | $27.0B |
| Interest CoverageEBIT ÷ Interest expense | 5.82x | 34.52x |
Total Returns (Dividends Reinvested)
CTVA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LIN five years ago would be worth $17,813 today (with dividends reinvested), compared to $17,540 for CTVA. Over the past 12 months, CTVA leads with a +32.1% total return vs LIN's +13.6%. The 3-year compound annual growth rate (CAGR) favors CTVA at 13.3% vs LIN's 12.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +20.9% | +17.3% |
| 1-Year ReturnPast 12 months | +32.1% | +13.6% |
| 3-Year ReturnCumulative with dividends | +45.5% | +41.9% |
| 5-Year ReturnCumulative with dividends | +75.4% | +78.1% |
| 10-Year ReturnCumulative with dividends | +195.9% | +376.9% |
| CAGR (3Y)Annualised 3-year return | +13.3% | +12.4% |
Risk & Volatility
LIN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than CTVA's 0.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.29x | 0.24x |
| 52-Week HighHighest price in past year | $85.63 | $521.28 |
| 52-Week LowLowest price in past year | $60.54 | $387.78 |
| % of 52W HighCurrent price vs 52-week peak | +95.5% | +96.3% |
| RSI (14)Momentum oscillator 0–100 | 64.4 | 50.6 |
| Avg Volume (50D)Average daily shares traded | 3.4M | 2.3M |
Analyst Outlook
LIN leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates CTVA as "Buy" and LIN as "Buy". Consensus price targets imply 7.8% upside for CTVA (target: $88) vs 7.5% for LIN (target: $540). For income investors, LIN offers the higher dividend yield at 1.20% vs CTVA's 0.86%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $88.17 | $539.71 |
| # AnalystsCovering analysts | 37 | 28 |
| Dividend YieldAnnual dividend ÷ price | +0.9% | +1.2% |
| Dividend StreakConsecutive years of raises | 5 | 6 |
| Dividend / ShareAnnual DPS | $0.71 | $6.00 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.0% | +2.0% |
LIN leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CTVA leads in 2 (Valuation Metrics, Total Returns).
CTVA vs LIN: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CTVA or LIN a better buy right now?
For growth investors, Linde plc (LIN) is the stronger pick with 3.
0% revenue growth year-over-year, versus 2. 9% for Corteva, Inc. (CTVA). Linde plc (LIN) offers the better valuation at 34. 4x trailing P/E (28. 1x forward), making it the more compelling value choice. Analysts rate Corteva, Inc. (CTVA) a "Buy" — based on 37 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CTVA or LIN?
On trailing P/E, Linde plc (LIN) is the cheapest at 34.
4x versus Corteva, Inc. at 51. 1x. On forward P/E, Corteva, Inc. is actually cheaper at 22. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Linde plc wins at 1. 11x versus Corteva, Inc. 's 1. 87x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — CTVA or LIN?
Over the past 5 years, Linde plc (LIN) delivered a total return of +78.
1%, compared to +75. 4% for Corteva, Inc. (CTVA). Over 10 years, the gap is even starker: LIN returned +376. 9% versus CTVA's +195. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CTVA or LIN?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
24β versus Corteva, Inc. 's 0. 29β — meaning CTVA is approximately 22% more volatile than LIN relative to the S&P 500. On balance sheet safety, Corteva, Inc. (CTVA) carries a lower debt/equity ratio of 11% versus 68% for Linde plc — giving it more financial flexibility in a downturn.
05Which is growing faster — CTVA or LIN?
By revenue growth (latest reported year), Linde plc (LIN) is pulling ahead at 3.
0% versus 2. 9% for Corteva, Inc. (CTVA). On earnings-per-share growth, the picture is similar: Corteva, Inc. grew EPS 23. 1% year-over-year, compared to 7. 1% for Linde plc. Over a 3-year CAGR, LIN leads at 0. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CTVA or LIN?
Linde plc (LIN) is the more profitable company, earning 20.
3% net margin versus 6. 3% for Corteva, Inc. — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus 15. 1% for CTVA. At the gross margin level — before operating expenses — CTVA leads at 43. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CTVA or LIN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Linde plc (LIN) is the more undervalued stock at a PEG of 1. 11x versus Corteva, Inc. 's 1. 87x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Corteva, Inc. (CTVA) trades at 22. 3x forward P/E versus 28. 1x for Linde plc — 5. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CTVA: 7. 8% to $88. 17.
08Which pays a better dividend — CTVA or LIN?
All stocks in this comparison pay dividends.
Linde plc (LIN) offers the highest yield at 1. 2%, versus 0. 9% for Corteva, Inc. (CTVA).
09Is CTVA or LIN better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
24), 1. 2% yield, +376. 9% 10Y return). Both have compounded well over 10 years (LIN: +376. 9%, CTVA: +195. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CTVA and LIN?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.